Drugplain

Sulfacetamide Sodium and Prednisolone Sodium Phosphate 2.3 mg/mL

Sulfacetamide Sodium and Prednisolone Sodium Phosphate · SOLUTION/ DROPS · Bausch & Lomb Incoporated

No Recall History
Plain English

Sulfacetamide Sodium and Prednisolone Sodium Phosphate is a solution/ drops containing sulfacetamide sodium and prednisolone sodium phosphate at 2.3 mg/mL, taken ophthalmic. Manufactured by Bausch & Lomb Incoporated.

Key Facts

Brand Name
Sulfacetamide Sodium and Prednisolone Sodium Phosphate
Generic Name
Sulfacetamide Sodium and Prednisolone Sodium Phosphate
NDC Code (Product)
24208-317
Manufacturer
Bausch & Lomb Incoporated
Strength
2.3 mg/mL
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Marketing Status
Application #
ANDA074449
Marketing Start
12/29/1995

Recall History

No Recall History

Frequently Asked Questions

What is Sulfacetamide Sodium and Prednisolone Sodium Phosphate used for?

Sulfacetamide Sodium and Prednisolone Sodium Phosphate contains Sulfacetamide Sodium and Prednisolone Sodium Phosphate. It is a solution/ drops taken ophthalmic. Consult your doctor for specific uses.

Is Sulfacetamide Sodium and Prednisolone Sodium Phosphate a controlled substance?

Sulfacetamide Sodium and Prednisolone Sodium Phosphate is not classified as a controlled substance by the DEA.

What is the generic name for Sulfacetamide Sodium and Prednisolone Sodium Phosphate?

The generic name for Sulfacetamide Sodium and Prednisolone Sodium Phosphate is Sulfacetamide Sodium and Prednisolone Sodium Phosphate. There are no other listed brand versions of Sulfacetamide Sodium and Prednisolone Sodium Phosphate.

What is the NDC code for Sulfacetamide Sodium and Prednisolone Sodium Phosphate 2.3 mg/mL?

The NDC (National Drug Code) for Sulfacetamide Sodium and Prednisolone Sodium Phosphate 2.3 mg/mL is 24208-317, listed by Bausch & Lomb Incoporated.

Product NDC

24208-317

Package NDC

24208-317-05

Other Sulfacetamide Sodium and Prednisolone Sodium Phosphate Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)